Page last updated: 2024-12-10

clinitest

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Clinitest: tablets used for testing urine for reducing substances; contains sodium hydroxide, copper sulfate, citric acid & sodium carbonate; accidental ingestion causes esophageal burn & stricture due to caustic NaOH [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080894
MeSH IDM0056768

Synonyms (7)

Synonym
1,2,3-propanetricarboxylic acid, 2-hydroxy-, mixt. with copper(2+) sulfate (1:1), sodium hydrogen carbonate and sodium hydroxide (na(oh))
63126-89-6
1,2,3-propanetricarboxylic acid, 2-hydroxy-, mixt. with copper(2+) sulfate (1:1), sodium hydrogen carbonate and sodium hydroxide
clinitest
benedict's reagent
DTXSID80212467
copper;disodium;hydrogen carbonate;2-hydroxypropane-1,2,3-tricarboxylic acid;hydroxide;sulfate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (70.00)18.7374
1990's2 (6.67)18.2507
2000's0 (0.00)29.6817
2010's2 (6.67)24.3611
2020's5 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 73.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index73.67 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index124.03 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (73.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.94%)5.53%
Reviews1 (2.94%)6.00%
Case Studies3 (8.82%)4.05%
Observational0 (0.00%)0.25%
Other29 (85.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]